Healthcare | April 27, 2026
IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach
The deal signals a clear push to expand access to care in underserved regions
The deal signals a clear push to expand access to care in underserved regions
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Growth was broad-based across segments
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
The system is powered by BrainSense technology, which has received approval from USFDA
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
Subscribe To Our Newsletter & Stay Updated
